Anti-Bag1 antibody [Y166]
- RabMAb
- Recombinant
- KO Validated
- What is this?
5
(4 Reviews)
|
(14 Publications)
Rabbit Recombinant Monoclonal BAG1 antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 14 publications.
View Alternative Names
HAP, BAG1, BAG family molecular chaperone regulator 1, BAG-1, Bcl-2-associated athanogene 1
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Bag1 antibody [Y166] (AB32109)
Immunofluorescent staining of HeLa cells using ab32109 at 1/100 dilution.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bag1 antibody [Y166] (AB32109)
Immunohistochemical analysis of paraffin-embedded human prostate carcinoma using ab32109 at 1/100 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-Bag1 antibody [Y166] (AB32109)
Western blot : Anti-Bag1 antibody [Y166] ab32109 staining at 1/500 dilution, shown in green; Mouse anti alpha Tubulin ab7291 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 32 kDa in Wild-type A549 cell lysates with no signal observed at this size in BAG1 knockout A549 cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-Bag1 antibody [Y166] (ab32109) at 1/500 dilution
Lane 1:
Wild-type A549 at 20 µg
Lane 2:
BAG1 knockout A549 at 20 µg
Lane 3:
THP-1 at 20 µg
Lane 4:
HT1080 at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 39 kDa
Observed band size: 32 kDa,51 kDa
true
Exposure time: 8s
- WB
Unknown
Western blot - Anti-Bag1 antibody [Y166] (AB32109)
All lanes:
Western blot - Anti-Bag1 antibody [Y166] (ab32109) at 1/500 dilution
All lanes:
HeLa cell lysate
Predicted band size: 39 kDa
Observed band size: 33 kDa,46 kDa,50 kDa
false
- WB
CiteAb
Western blot - Anti-Bag1 antibody [Y166] (AB32109)
Bag1 western blot using anti-Bag1 antibody [Y166] ab32109. Publication image and figure legend from Wood, R. J., Ormsby, A. R., et al., 2018, Nat Commun, PubMed 29348634.
ab32109 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab32109 please see the product overview.
Probing changes in proteostasis through selective activation of different chaperone systems. a Investigation of the effect of induction of the heat shock response by HSF1 overexpression or selective overexpression of HSP90. Shown on left are western blots of the HEK293T cells matched for total protein via a BCA assay. These cells were co-transfected with HSF1 (or myc-tagged HSP90 or control of (non-fluorescent) Y66L Emerald fluorescent protein) and the L89G barnase biosensor (which also contains a myc tag). The right graphs show the Lower-slope and A50% analyses of these treatments and one or three of the biosensor variants as indicated vs. the wild-type* variant. Bars indicate means ± SEM. The right panels were analysed via a two-way ANOVA subjected to a Dunnett's post-hoc test, results coded as ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05, ns = > 0.05. b Same paradigm as panel a. In this case, BAG1 was cotransfected with the barnase biosensor, HSP40 (DNAJB1) and HSP70 (HSPA1A). The right panels show the proportional dosage of each construct (by mass of DNA) in the transfection. Bars indicate means ± SEM. The right panel Lower-slope graph was analysed via a two-way ANOVA subjected to Dunnett's post hoc test and the A50% graph was analysed via a one-way ANOVA subjected to a Tukey's post-hoc test. Results coded as ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05, ns = > 0.05
false
Related conjugates and formulations (1)
-
Anti-Bag1 antibody [Y166] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Bag1 plays essential roles in regulating cell survival and apoptosis. It can exist as part of a larger protein complex and is known to bind with the anti-apoptotic protein Bcl-2 enhancing cell survival. By interacting with these proteins Bag1 helps control the delicate balance between cell death and survival critical for normal cellular function and response to stress. Bag1 also affects transcription regulation cell cycle progression and cellular response to stress stimuli.
Pathways
Bag1 integrates into cellular stress response and apoptotic signaling pathways. Bag1's interaction with Hsp70 associates it with the heat shock response pathway which upregulates molecular chaperones to protect cells during stress. Additionally its binding to Bcl-2 situates it within the apoptotic pathway where it supports cell survival by inhibiting caspase activation. The protein further interacts with key regulatory proteins like Raf-1 linking it to the MAPK/ERK signaling pathway involved in cell growth and division.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
Cell discovery 11:19 PubMed40038243
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 42:113529 PubMed38060380
2023
Applications
Unspecified application
Species
Unspecified reactive species
Analytical cellular pathology (Amsterdam) 2023:4500810 PubMed38077523
2023
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 11: PubMed36979842
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Cancer 12:4780-4790 PubMed34234849
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neurochemistry 158:358-372 PubMed33025573
2020
Applications
Unspecified application
Species
Unspecified reactive species
Bioscience reports 39: PubMed31189742
2019
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 19:258 PubMed30902071
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 41:1901-1910 PubMed30747221
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 17:7435-7441 PubMed29568970
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com